{{Rsnum
|rsid=1468271
|Gene=NPY
|Chromosome=7
|position=24287362
|Orientation=minus
|GMAF=0.01607
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=NPY
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19846279
|Title=Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels
|OA=1
}}

{{PMID|16700901|OA=1
}} Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction.

{{PMID|18031993}} Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.

{{PMID|18254975|OA=1
}} Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.

{{PMID|18996102}} Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.

{{PMID|19119412|OA=1
}} Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}